Table 1.
Variables | Number of patients |
Gender | |
Male | 47 (73.4) |
Female | 17 (26.6) |
Age at diagnosis | 27.5 (8, 78) |
Disease period before operation | 9.5 (2.0, 48.0) |
Montreal classification | |
Age, yr | |
A1 (≤ 16) | 6 (9.4) |
A2 (17-40) | 49 (76.6) |
A3 (> 40) | 9 (14.1) |
Behavior | |
B1 (Inflammatory) | 2 (3.1) |
B2 (Stricturing) | 25 (39.1) |
B3 (Penetrating) | 37 (57.8) |
Location | |
L1 (Terminal ileum) | 9 (14.1) |
L2 (Colon) | 1 (1.6) |
L3 (Ileocolon) | 47 (73.4) |
L4 (Upper disease) | 7 (10.9) |
Perianal disease | 22 (34.4) |
Preoperative use of medication | 29 (45.3) |
Steroid | 23 (35.9) |
Immunomodulator | 24 (37.5) |
Anti-TNF | 4 (6.2) |
TNF: Tumor necrosis factor.